Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195 | 6 | 31 | 11 | 11 |
| Receivables | 28 | 13 | 24 | 17 | 16 |
| TOTAL | $570 | $57 | $206 | $188 | $273 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 4 | 7 | 11 |
| TOTAL | $N/A | $N/A | $4 | $7 | $11 |
| Total Assets | $570 | $57 | $210 | $195 | $284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 211 | 201 |
| Accounts payable and accrued liabilities | 4,533 | 4,898 | 4,209 | 4,180 | 4,047 |
| Other current liabilities | 546 | 510 | 501 | 509 | 304 |
| TOTAL | $5,142 | $5,469 | $4,740 | $4,930 | $4,583 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 29 | 29 | 28 |
| Other Non-Current Liabilities | 948 | 320 | 718 | 505 | 570 |
| TOTAL | $481 | $353 | $444 | $532 | $598 |
| Total Liabilities | $5,623 | $5,822 | $5,184 | $5,462 | $5,182 |
| Shareholders' Equity | |||||
| Common Shares | 61,507 | 58,649 | 57,513 | 58,623 | 59,549 |
| Retained earnings | -88,842 | -85,845 | -83,824 | -83,380 | -83,823 |
| Other shareholders' equity | 22,282 | 21,432 | 21,337 | 19,489 | 19,376 |
| TOTAL | $-5,053 | $-5,765 | $-4,974 | $-5,268 | $-4,898 |
| Total Liabilities And Equity | $570 | $57 | $210 | $195 | $284 |